COMT inhibitors
Entacapone, opicapone and tolcapone — extending levodopa effect, off-time reduction and hepatic-safety considerations.
State of the art
No update yet for COMT inhibitors. An update is a standalone state-of-the-art for the topic — what someone with Parkinson's needs to know about where this approach stands today.
No reader summaries on this topic yet.